Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis

Juliane Tschuck(Helmholtz Zentrum München), Lea Theilacker(Helmholtz Zentrum München), Ina Rothenaigner(Helmholtz Zentrum München), Stefanie Weiß(Helmholtz Zentrum München), Banu Akdogan(Helmholtz Zentrum München), Van Thanh Lam(Helmholtz Zentrum München), Constanze Müller(Helmholtz Zentrum München), Roman Graf(Helmholtz Zentrum München), Stefanie Brandner(Helmholtz Zentrum München), Christian Pütz(Helmholtz Zentrum München), Tamara Rieder(Technical University of Munich), Philippe Schmitt‐Kopplin(Helmholtz Zentrum München), Michelle Vincendeau(Helmholtz Zentrum München), Hans Zischka(Helmholtz Zentrum München), Kenji Schorpp(Helmholtz Zentrum München), Kamyar Hadian(Helmholtz Zentrum München)
Nature Communications
October 30, 2023
Cited by 90Open Access
Full Text

Abstract

Ferroptosis is a regulated cell death modality that occurs upon iron-dependent lipid peroxidation. Recent research has identified many regulators that induce or inhibit ferroptosis; yet, many regulatory processes and networks remain to be elucidated. In this study, we performed a chemical genetics screen using small molecules with known mode of action and identified two agonists of the nuclear receptor Farnesoid X Receptor (FXR) that suppress ferroptosis, but not apoptosis or necroptosis. We demonstrate that in liver cells with high FXR levels, knockout or inhibition of FXR sensitized cells to ferroptotic cell death, whereas activation of FXR by bile acids inhibited ferroptosis. Furthermore, FXR inhibited ferroptosis in ex vivo mouse hepatocytes and human hepatocytes differentiated from induced pluripotent stem cells. Activation of FXR significantly reduced lipid peroxidation by upregulating the ferroptosis gatekeepers GPX4, FSP1, PPARα, SCD1, and ACSL3. Together, we report that FXR coordinates the expression of ferroptosis-inhibitory regulators to reduce lipid peroxidation, thereby acting as a guardian of ferroptosis.


Related Papers